Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.07
NAS:MDRX's Cash-to-Debt is ranked lower than
96% of the 1921 Companies
in the Global Software - Application industry.

( Industry Median: 10.13 vs. NAS:MDRX: 0.07 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:MDRX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07  Med: 0.57 Max: No Debt
Current: 0.07
Equity-to-Asset 0.32
NAS:MDRX's Equity-to-Asset is ranked lower than
82% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. NAS:MDRX: 0.32 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:MDRX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.3  Med: 0.59 Max: 0.95
Current: 0.32
0.3
0.95
Interest Coverage 1.20
NAS:MDRX's Interest Coverage is ranked lower than
96% of the 1467 Companies
in the Global Software - Application industry.

( Industry Median: 173.79 vs. NAS:MDRX: 1.20 )
Ranked among companies with meaningful Interest Coverage only.
NAS:MDRX' s Interest Coverage Range Over the Past 10 Years
Min: 0.82  Med: 5.97 Max: 52.48
Current: 1.2
0.82
52.48
Piotroski F-Score: 4
Altman Z-Score: 0.88
Beneish M-Score: -2.67
WACC vs ROIC
4.03%
0.91%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 3.86
NAS:MDRX's Operating Margin % is ranked lower than
54% of the 1862 Companies
in the Global Software - Application industry.

( Industry Median: 4.84 vs. NAS:MDRX: 3.86 )
Ranked among companies with meaningful Operating Margin % only.
NAS:MDRX' s Operating Margin % Range Over the Past 10 Years
Min: -9.29  Med: 6.12 Max: 14.84
Current: 3.86
-9.29
14.84
Net Margin % -1.66
NAS:MDRX's Net Margin % is ranked lower than
67% of the 1863 Companies
in the Global Software - Application industry.

( Industry Median: 3.19 vs. NAS:MDRX: -1.66 )
Ranked among companies with meaningful Net Margin % only.
NAS:MDRX' s Net Margin % Range Over the Past 10 Years
Min: -7.58  Med: 2.33 Max: 8.92
Current: -1.66
-7.58
8.92
ROE % -1.92
NAS:MDRX's ROE % is ranked lower than
68% of the 1803 Companies
in the Global Software - Application industry.

( Industry Median: 6.16 vs. NAS:MDRX: -1.92 )
Ranked among companies with meaningful ROE % only.
NAS:MDRX' s ROE % Range Over the Past 10 Years
Min: -7.99  Med: 2.46 Max: 8.34
Current: -1.92
-7.99
8.34
ROA % -0.77
NAS:MDRX's ROA % is ranked lower than
64% of the 1927 Companies
in the Global Software - Application industry.

( Industry Median: 2.92 vs. NAS:MDRX: -0.77 )
Ranked among companies with meaningful ROA % only.
NAS:MDRX' s ROA % Range Over the Past 10 Years
Min: -4.19  Med: 1.68 Max: 6.14
Current: -0.77
-4.19
6.14
ROC (Joel Greenblatt) % 25.73
NAS:MDRX's ROC (Joel Greenblatt) % is ranked higher than
52% of the 1883 Companies
in the Global Software - Application industry.

( Industry Median: 23.13 vs. NAS:MDRX: 25.73 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:MDRX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -74.39  Med: 51.26 Max: 172.68
Current: 25.73
-74.39
172.68
3-Year Revenue Growth Rate 2.40
NAS:MDRX's 3-Year Revenue Growth Rate is ranked lower than
60% of the 1454 Companies
in the Global Software - Application industry.

( Industry Median: 5.30 vs. NAS:MDRX: 2.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:MDRX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -28.6  Med: 8.9 Max: 24.3
Current: 2.4
-28.6
24.3
3-Year EBITDA Growth Rate 62.60
NAS:MDRX's 3-Year EBITDA Growth Rate is ranked higher than
93% of the 1210 Companies
in the Global Software - Application industry.

( Industry Median: 8.40 vs. NAS:MDRX: 62.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:MDRX' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -68.8  Med: 7.45 Max: 105.4
Current: 62.6
-68.8
105.4
3-Year EPS without NRI Growth Rate -38.10
NAS:MDRX's 3-Year EPS without NRI Growth Rate is ranked lower than
89% of the 1098 Companies
in the Global Software - Application industry.

( Industry Median: 7.70 vs. NAS:MDRX: -38.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:MDRX' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -61.2  Med: 0 Max: 88.2
Current: -38.1
-61.2
88.2
GuruFocus has detected 2 Warning Signs with Allscripts Healthcare Solutions Inc $NAS:MDRX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:MDRX's 10-Y Financials

Financials (Next Earnings Date: 2017-05-04)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

MDRX Guru Trades in Q1 2016

First Eagle Investment 5,963,023 sh (+15.44%)
Chuck Royce 1,643,400 sh (+0.31%)
Michael Price 477,500 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Jim Simons Sold Out
RS Investment Management 2,866,712 sh (-19.40%)
Third Avenue Management 204,351 sh (-31.32%)
Joel Greenblatt 160,157 sh (-89.18%)
» More
Q2 2016

MDRX Guru Trades in Q2 2016

Paul Tudor Jones 36,902 sh (New)
Jim Simons 251,865 sh (New)
Joel Greenblatt 186,620 sh (+16.52%)
Chuck Royce 1,666,900 sh (+1.43%)
Third Avenue Management 204,351 sh (unchged)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
RS Investment Management 2,864,495 sh (-0.08%)
First Eagle Investment 4,774,073 sh (-19.94%)
» More
Q3 2016

MDRX Guru Trades in Q3 2016

Steven Cohen 347,900 sh (New)
Jim Simons 698,465 sh (+177.32%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
Third Avenue Management 204,351 sh (unchged)
Joel Greenblatt Sold Out
Chuck Royce 1,645,400 sh (-1.29%)
First Eagle Investment 4,578,690 sh (-4.09%)
Paul Tudor Jones 16,800 sh (-54.47%)
» More
Q4 2016

MDRX Guru Trades in Q4 2016

George Soros 38,900 sh (New)
Paul Tudor Jones 22,900 sh (+36.31%)
Chuck Royce 1,859,600 sh (+13.02%)
Vanguard Health Care Fund 11,198,893 sh (unchged)
Michael Price 477,500 sh (unchged)
Steven Cohen Sold Out
Jim Simons Sold Out
Third Avenue Management 203,687 sh (-0.32%)
First Eagle Investment 4,105,150 sh (-10.34%)
» More
» Details

Insider Trades

Latest Guru Trades with MDRX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Software - Application    NAICS: 541519    SIC: 7373
Compare:NAS:MSTR, NYSE:RNG, NYSE:HUBS, OTCPK:ISMAY, NAS:CSOD, NYSE:LXFT, NAS:FEYE, NAS:TIVO, NAS:CVLT, NAS:STMP, NAS:PCTY, NYSE:DBD, NAS:EBIX, NAS:ACIW, NYSE:TWLO, NAS:SYNA, NAS:DSGX, OTCPK:SPHHF, NAS:VRNT, OTCPK:AVEVF » details
Traded in other countries:AL21.Germany,
Headquarter Location:USA
Allscripts Healthcare Solutions Inc is a provider of clinical, financial, connectivity and information solutions and related professional services that empower hospitals, physicians and post-acute organizations to deliver world-class outcomes.

Allscripts Healthcare Solutions delivers information technology and services to healthcare organizations. The clinical and financial solutions segment sells software applications and financial and information solutions, including electronic health records and practice management software, revenue cycle management, support, and maintenance. The population health segment sells health management and coordinated care solutions to health systems, hospitals, and accountable care organizations. Allscripts is headquartered in Chicago.

Top Ranked Articles about Allscripts Healthcare Solutions Inc

Concentra to launch Allscripts Practice Management for optimal efficiency and productivity
Allscripts eChart™ Courier service exchanges 10 million records
Allscripts Professional EHR™ first health IT solution to deliver fully certified 2015 edition technology with Drummond Group LLC
Allscripts announces dbMotion™ Solution now available through cloud on Microsoft Azure
Allscripts to release first quarter 2017 financial results May 4
Allscripts hosts Investor Conference in New York City

CHICAGO, March 21, 2017 (GLOBE NEWSWIRE) -- As previously announced, members of Allscripts (NASDAQ:MDRX) management team are hosting an Investor Day for the financial community today, March 21, 2017, in New York City. The event is scheduled to begin at 8:00 a.m. ET and will conclude at 1:30 p.m. ET.
Allscripts leadership team will present financial information and an overview of the company's strategic vision and growth strategy for domestic core systems, global markets, value-based care and post-acute segments. The event will be live webcasted and presentation materials will be available at Allscripts investor relations website. About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog. © 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved. Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:

Investors:
Seth Frank
312-506-1213
[email protected]

Media:
Concetta Rasiarmos
312-447-2466
[email protected]

Read more...
Leading U.S. health providers choose EPSi™ decision support platform to improve financial performance

Momentum shows EPSi’s success in empowering clients to meet rapidly changing market needs

CHICAGO, March 09, 2017 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ:MDRX) flagship budgeting, long-range planning, cost accounting and financial decision support platform, is entering the new year with momentum after signing several new clients in the fourth quarter of 2016. EPSi is a leader in integrated financial decision support, budgeting and planning solutions for the healthcare industry. More than 900 hospitals in the U.S., including nine of the top 10 rated hospitals, 128 IDN systems, and 40 global academic facilities rely on EPSi for data-driven insight into managing costs and improving their long-range financial performance. Beaumont Health System chose EPSi as it went through a concentrated effort to consolidate all functional applications after a recent merger of its 8 hospital facilities. EPSi will drive Beaumont’s key financial planning and decision support processes, building an annual operating budget and creating a full system-wide decision support capability procedure that will help Beaumont manage the shift to value-based care reimbursement and bundled payments. EPSi will also enable Beaumont to facilitate long-range financial planning across its newly merged system. “Allscripts EPSi will unlock an integrated view of our finances and operations across our entire health system,” said John Kerndl, Executive Vice President and CFO. “This broad view enables us to better plan for our financial health and will help us in our transition from volume to value.” Yuma Regional Medical Center will use EPSi to help achieve its operating budget for the next fiscal year and optimize its financial plan for the future. Yuma Regional will also use EPSi to implement a fully functional decision support and cost accounting process, which is expected to positively impact its organizational performance profitability.    “EPSi will help us combine clinical and financial data for more complete and accurate decision support information,” said David Willie, Yuma Regional Chief Financial Officer. “EPSi offers deeper functionality and an integrated data model that we didn’t find in other solutions in the market.” Wise Health System selected EPSi for its integrated cost accounting, budgeting and long range planning, reporting and analytics tools that will help drive Wise Health’s strategic financial decisions. Wise Health expects to be able to plan budgets more accurately and efficiently, and connect to powerful long-range planning and forecasting capabilities.  Wise Health is also contracted to use Allscripts Sunrise™, a highly configurable electronic health record that offers workflows to help drive adoption of clinical decision support, and CareInMotion™, a comprehensive, adaptable framework that enables healthcare organizations to address their specific population health priorities, such as connectivity, care coordination, analytics and patient engagement. “Healthcare systems face increasingly complex demands on their financial organizations. New requirements such as bundled payments, accountable care organizations and population health initiatives are forcing hospitals to analyze more data than ever,” said Ralph Keiser, EPSi Chief Executive Officer. “EPSi provides the tools clients need to incorporate, analyze and utilize data to drive the organizational transformation required to succeed in the transition from volume to value. We are powering the value equation in population health management.” About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more about EPSi visit www.epsi.io. © 2017 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved. Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information, contact:

Investors:
Seth Frank
312-506-1213
[email protected]

Media:
Concetta Rasiarmos
312-447-2466
[email protected]

Read more...

Ratios

vs
industry
vs
history
Forward PE Ratio 19.05
MDRX's Forward PE Ratio is ranked higher than
52% of the 535 Companies
in the Global Software - Application industry.

( Industry Median: 20.20 vs. MDRX: 19.05 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
Price-to-Owner-Earnings 27.99
MDRX's Price-to-Owner-Earnings is ranked lower than
62% of the 724 Companies
in the Global Software - Application industry.

( Industry Median: 22.94 vs. MDRX: 27.99 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
MDRX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.61  Med: 34.82 Max: 840
Current: 27.99
8.61
840
PB Ratio 1.77
MDRX's PB Ratio is ranked higher than
68% of the 1789 Companies
in the Global Software - Application industry.

( Industry Median: 2.97 vs. MDRX: 1.77 )
Ranked among companies with meaningful PB Ratio only.
MDRX' s PB Ratio Range Over the Past 10 Years
Min: 0.79  Med: 2.09 Max: 5.17
Current: 1.77
0.79
5.17
PS Ratio 1.41
MDRX's PS Ratio is ranked higher than
62% of the 1780 Companies
in the Global Software - Application industry.

( Industry Median: 2.34 vs. MDRX: 1.41 )
Ranked among companies with meaningful PS Ratio only.
MDRX' s PS Ratio Range Over the Past 10 Years
Min: 0.9  Med: 2.17 Max: 7.04
Current: 1.41
0.9
7.04
Price-to-Free-Cash-Flow 17.02
MDRX's Price-to-Free-Cash-Flow is ranked higher than
65% of the 677 Companies
in the Global Software - Application industry.

( Industry Median: 24.32 vs. MDRX: 17.02 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
MDRX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.06  Med: 34.98 Max: 2138.46
Current: 17.02
10.06
2138.46
Price-to-Operating-Cash-Flow 8.29
MDRX's Price-to-Operating-Cash-Flow is ranked higher than
81% of the 856 Companies
in the Global Software - Application industry.

( Industry Median: 17.68 vs. MDRX: 8.29 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
MDRX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.77  Med: 21.92 Max: 79.2
Current: 8.29
5.77
79.2
EV-to-EBIT 102.45
MDRX's EV-to-EBIT is ranked lower than
91% of the 1770 Companies
in the Global Software - Application industry.

( Industry Median: 17.68 vs. MDRX: 102.45 )
Ranked among companies with meaningful EV-to-EBIT only.
MDRX' s EV-to-EBIT Range Over the Past 10 Years
Min: -1965.5  Med: 35.9 Max: 540.1
Current: 102.45
-1965.5
540.1
EV-to-EBITDA 17.29
MDRX's EV-to-EBITDA is ranked lower than
60% of the 1910 Companies
in the Global Software - Application industry.

( Industry Median: 13.76 vs. MDRX: 17.29 )
Ranked among companies with meaningful EV-to-EBITDA only.
MDRX' s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.1  Med: 22.9 Max: 83.8
Current: 17.29
7.1
83.8
Shiller PE Ratio 226.70
MDRX's Shiller PE Ratio is ranked lower than
98% of the 291 Companies
in the Global Software - Application industry.

( Industry Median: 38.24 vs. MDRX: 226.70 )
Ranked among companies with meaningful Shiller PE Ratio only.
MDRX' s Shiller PE Ratio Range Over the Past 10 Years
Min: 45.6  Med: 114.39 Max: 253.6
Current: 226.7
45.6
253.6
Current Ratio 0.91
MDRX's Current Ratio is ranked lower than
86% of the 1750 Companies
in the Global Software - Application industry.

( Industry Median: 1.94 vs. MDRX: 0.91 )
Ranked among companies with meaningful Current Ratio only.
MDRX' s Current Ratio Range Over the Past 10 Years
Min: 0.91  Med: 1.75 Max: 9.91
Current: 0.91
0.91
9.91
Quick Ratio 0.91
MDRX's Quick Ratio is ranked lower than
84% of the 1750 Companies
in the Global Software - Application industry.

( Industry Median: 1.79 vs. MDRX: 0.91 )
Ranked among companies with meaningful Quick Ratio only.
MDRX' s Quick Ratio Range Over the Past 10 Years
Min: 0.8  Med: 1.66 Max: 9.36
Current: 0.91
0.8
9.36
Days Sales Outstanding 95.42
MDRX's Days Sales Outstanding is ranked lower than
70% of the 1492 Companies
in the Global Software - Application industry.

( Industry Median: 68.98 vs. MDRX: 95.42 )
Ranked among companies with meaningful Days Sales Outstanding only.
MDRX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 76.24  Med: 90.35 Max: 105.33
Current: 95.42
76.24
105.33
Days Payable 52.39
MDRX's Days Payable is ranked higher than
56% of the 1330 Companies
in the Global Software - Application industry.

( Industry Median: 43.37 vs. MDRX: 52.39 )
Ranked among companies with meaningful Days Payable only.
MDRX' s Days Payable Range Over the Past 10 Years
Min: 19.32  Med: 30.68 Max: 52.39
Current: 52.39
19.32
52.39

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -1.20
MDRX's 3-Year Average Share Buyback Ratio is ranked higher than
61% of the 1148 Companies
in the Global Software - Application industry.

( Industry Median: -2.60 vs. MDRX: -1.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
MDRX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -102.2  Med: -9.9 Max: 1.8
Current: -1.2
-102.2
1.8

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.20
MDRX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
73% of the 771 Companies
in the Global Software - Application industry.

( Industry Median: 1.97 vs. MDRX: 1.20 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
MDRX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.9  Med: 1.75 Max: 6.47
Current: 1.2
0.9
6.47
Price-to-Median-PS-Value 0.66
MDRX's Price-to-Median-PS-Value is ranked higher than
87% of the 1498 Companies
in the Global Software - Application industry.

( Industry Median: 1.15 vs. MDRX: 0.66 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
MDRX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.54  Med: 1.16 Max: 10.38
Current: 0.66
0.54
10.38
Earnings Yield (Greenblatt) % 0.98
MDRX's Earnings Yield (Greenblatt) % is ranked lower than
62% of the 2521 Companies
in the Global Software - Application industry.

( Industry Median: 3.23 vs. MDRX: 0.98 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
MDRX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 0.2  Med: 2.2 Max: 5.9
Current: 0.98
0.2
5.9
Forward Rate of Return (Yacktman) % 4.88
MDRX's Forward Rate of Return (Yacktman) % is ranked lower than
65% of the 773 Companies
in the Global Software - Application industry.

( Industry Median: 10.33 vs. MDRX: 4.88 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
MDRX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -12.5  Med: 2.8 Max: 69.6
Current: 4.88
-12.5
69.6

More Statistics

Revenue (TTM) (Mil) $1,550
EPS (TTM) $ -0.14
Beta1.23
Short Percentage of Float12.36%
52-Week Range $9.80 - 15.17
Shares Outstanding (Mil)181.46

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 1,715 1,819 1,917
EPS ($) 0.62 0.72 0.82
EPS without NRI ($) 0.62 0.72 0.82
EPS Growth Rate
(Future 3Y To 5Y Estimate)
13.33%
Dividends per Share ($)
» More Articles for MDRX

Headlines

Articles On GuruFocus.com
Concentra to launch Allscripts Practice Management for optimal efficiency and productivity Apr 26 2017 
Allscripts eChart™ Courier service exchanges 10 million records Apr 24 2017 
Allscripts Professional EHR™ first health IT solution to deliver fully certified 2015 edition t Apr 20 2017 
Allscripts announces dbMotion™ Solution now available through cloud on Microsoft Azure Apr 11 2017 
Allscripts to release first quarter 2017 financial results May 4 Apr 06 2017 
Allscripts hosts Investor Conference in New York City Mar 21 2017 
Leading U.S. health providers choose EPSi™ decision support platform to improve financial perfo Mar 09 2017 
The Moat Stays Strong, Even If the Listing Is Gone Oct 24 2016 
Companies Fall to 5-Year Lows Jun 22 2016 
Netsmart Finalizes Home Health, Hospice and Investor Partner Transaction Apr 19 2016 

More From Other Websites
Concentra to launch Allscripts Practice Management for optimal efficiency and productivity Apr 26 2017
Allscripts eChart™ Courier service exchanges 10 million records Apr 24 2017
Allscripts Professional EHR™ first health IT solution to deliver fully certified 2015 edition... Apr 20 2017
Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner :... Apr 14 2017
Allscripts' (MDRX) dbMotion Solution Available Through Azure Apr 12 2017
Allscripts announces dbMotion™ Solution now available through cloud on Microsoft Azure Apr 11 2017
Allscripts to release first quarter 2017 financial results May 4 Apr 06 2017
Streamline Health® Announces New Reseller Agreement With Allscripts Mar 28 2017
Allscripts Healthcare Solutions (MDRX) Jumps: Stock Rises 7% Mar 28 2017
Allscripts Healthcare Solutions, Inc. breached its 50 day moving average in a Bearish Manner :... Mar 23 2017
Allscripts hosts Investor Conference in New York City Mar 21 2017
Leading U.S. health providers choose EPSi™ decision support platform to improve financial... Mar 09 2017
Allscripts (MDRX) Acknowledged by LPP's CDIS Framework Mar 07 2017
Allscripts accepted onto NHS London Procurement Partnership's Clinical and Digital Information... Mar 06 2017
Allscripts Launches Clinical Pathways for Cancer Treatment Feb 28 2017
Cancer Treatment Centers of America® Partners with Allscripts and NantHealth to Launch Clinical... Feb 27 2017
Allscripts Healthcare Solutions, Inc. :MDRX-US: Earnings Analysis: 2016 By the Numbers : February... Feb 22 2017
2bPrecise Announces General Availability of Precision Medicine Platform Feb 20 2017
Allscripts (MDRX) Q4 Earnings Miss Estimates, View Upbeat Feb 17 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)